Pharmacological treatment of chronic heart failure

被引：0
作者：
Rachele Adorisio
Leonardo De Luca
Joseph Rossi
Mihai Gheorghiade
机构：
[1] Ospedale Bambino Gesù,Department of Cardiology and Cardiac Surgery
[2] European Hospital,Division of Cardiology
[3] Northwestern University,undefined
[4] Feinberg School of Medicine,undefined
[5] Northwestern University,undefined
[6] Feinberg School of Medicine,undefined
来源：
Heart Failure Reviews | 2006年 / 11卷
关键词：
Heart failure; Drugs; Angiotensin-converting enzyme inhibitors; β-blockers; Diuretics; Digitalis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Heart failure (HF) is associated with a high morbidity and mortality in the Western World. Our knowledge of the epidemiology, pathophysiology, and therapy has improved dramatically during the last 20 years. Pharmacological treatment, as it stands today, is a combination of preventive and symptomatic strategies. The mainstay life-saving drugs are angiotensin-converting enzyme inhibitors and β-blockers. Additional benefits are obtained when angiotensin-receptor blockers or aldosterone antagonists are added. Digitalis and/or diuretics are useful for symptom reduction. In addition, combination therapy with hydralazine and isosorbide dinitrate is recommended in African Americans.
引用
收藏
页码：109 / 123
页数：14
相关论文
共 496 条
  • [1] Stewart S(2003)Heart failure and the aging population: an increasing burden in the 21st century Heart 89 49-53
  • [2] MacIntyre K(2002)Congestive heart failure: fifty years of progress Circulation 102 IV14-IV23
  • [3] Capewell S(1999)Mechanisms and models in heart failure: a combinatorial approach Circulation 100 999-1008
  • [4] McMurray JJ(2001)Pathophysiology of chronic heart failure Am J Med 110 37S-46S
  • [5] Braunwald E(2005)Heart Failure Lancet 365 1877-89
  • [6] Bristow MR(1999)Chronic heart failure in the United States: a manifestation of coronary artery disease Circulation 97 282-9
  • [7] Mann D(1996)Prolonged impairment of regional contractile function after resolution of exercise induced angina: evidence of myocardial stunning in patients with coronary artery disease Circulation 94 2455-2464
  • [8] Francis GS(1995)The hibernating myocardium: implications for management of congestive heart failure Am J Cardiol 75 17A-25A
  • [9] McMurray JJ(2000)Apoptotic cell death in heart failure Cardiovasc Res 45 704-712
  • [10] Pfeffer M(2000)Importance of neuroendocrine activation in chronic heart failure: impact on treatment strategies Eur J Heart Fail 2 229-33
12345678910